Meningioma 1 Antikörper
-
- Target Alle Meningioma 1 (MN1) Antikörper anzeigen
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Meningioma 1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- meningioma(disrupted in balanced translocation) 1
- Isotyp
- IgG
- Top Product
- Discover our top product MN1 Primärantikörper
-
-
- Applikationshinweise
- IHC: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
- Andere Bezeichnung
- MN1 (MN1 Produkte)
- Synonyme
- MGCR antikoerper, MGCR1 antikoerper, MGCR1-PEN antikoerper, dJ353E16.2 antikoerper, MN1 proto-oncogene, transcriptional regulator antikoerper, MN1 antikoerper
- Hintergrund
- Synonyms: Background:Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull(By similarity). May play a role in tumor suppression(Probable).
- Gen-ID
- 4330
- UniProt
- Q10571
-